2019 American Society of Hematology Annual Meeting*

December 7-10, 2019; Orlando, Florida
Review slidesets and analyses of key data from the 2019 Hematology meeting.
Hanny Al-Samkari, MD
John M. Burke, MD
Elias Jabbour, MD
Rami S. Komrokji, MD
Shaji Kumar, MD
Sagar Lonial, MD
Raajit K. Rampal, MD, PhD
Jeff P. Sharman, MD
Sujit Sheth, MD
Eunice S. Wang, MD

ClinicalThought

Experts highlight key data to help you learn what to expect at the upcoming Hematology meeting in Orlando. The CCO Conference Coverage program will feature downloadable slides and expert commentaries of clinically relevant studies presented at ASH 2019. We will have the information you need to understand and integrate the latest hematology data into your practice.

Hanny Al-Samkari, MD John M. Burke, MD Elias Jabbour, MD Rami S. Komrokji, MD Shaji Kumar, MD Sagar Lonial, MD Raajit K. Rampal, MD, PhD Jeff P. Sharman, MD Sujit Sheth, MD Eunice S. Wang, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: December 5, 2019 Expired: December 4, 2020

Review the most clinically relevant data in leukemias, lymphomas, MDS, MPNs, multiple myeloma, and nonmalignant hematologic disorders presented at the 2019 ASH Annual Meeting.

Hanny Al-Samkari, MD Rami S. Komrokji, MD Sagar Lonial, MD Jeff P. Sharman, MD Sujit Sheth, MD Eunice S. Wang, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: March 17, 2020 Expired: March 16, 2021

Acute and Chronic Leukemias

Get expert perspective on the key studies in AML and ALL from ASH 2019 that may impact your practice and help you to improve patient outcomes.

Eunice S. Wang, MD Released: February 3, 2020

Lymphomas and Chronic Lymphocytic Leukemia

Are you aware of the latest clinical data in CLL and lymphomas? In this commentary, Jeff P. Sharman, MD, discusses 5 key studies on CLL/lymphomas that were recently presented at ASH 2019.

Jeff P. Sharman, MD Released: January 23, 2020

Multiple Myeloma

Did you see the latest clinical data in myeloma? In this commentary, Sagar Lonial, MD, discusses the key studies on myeloma that were recently presented at ASH 2019.

Sagar Lonial, MD Released: February 26, 2020
Provided by the Annenberg Center for Health Sciences at Eisenhower in partnership with Clinical Care Options.
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Supported by educational grants from
AstraZeneca
Celgene Corporation
Dova Pharmaceuticals, Inc.
Karyopharm Therapeutics
Loxo Oncology, Inc. a wholly owned subsidiary of Eli Lilly and Company
Pharmacyclics LLC, an AbbVie Company
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?